Climate Change Data

Jenscare Scientific Co., Ltd. (寧波健世科技股份有限公司)

Climate Impact & Sustainability Data (2022, 2023)

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:1270.5 tCO2e/year
Scope 1 Emissions:23.4 tCO2e/year
Scope 2 Emissions:1247.1 tCO2e/year
Total Energy Consumption:1.55 million kWh/year
Water Consumption:12,000 m3/year
Waste Generated:0.2 tons/year

ESG Focus Areas

  • Environmental Protection
  • Employee Well-being
  • Supply Chain Management
  • Intellectual Property
  • Anti-corruption

Environmental Achievements

  • Implemented energy saving and emission reduction measures, using energy-saving equipment, and enhancing the recycle of waste parts of equipment.
  • Reduced exhaust gas emissions to approximately 62.7 kg, with an emission intensity of approximately 0.2 kg/person.
  • Reduced greenhouse gas emissions to approximately 1,270.5 tonnes of carbon dioxide equivalent, with an emission intensity of approximately 4,351.0 kg of carbon dioxide equivalent/person.

Social Achievements

  • Established a fair and transparent performance management system.
  • Provided various benefits and allowances to its employees, including paid holidays, supplementary medical insurance, long service awards, accommodation and transportation subsidies, meal subsidies, high temperature subsidies and preferential rental flats.
  • Implemented a system for approving applications for overtime work, under which employees are required to submit applications for overtime work in advance for approval by their supervisors.
  • Provided annual health check-ups for its employees and established employee health records.

Governance Achievements

  • Established a comprehensive supplier management system.
  • Established a sound quality management system.
  • Established the Product Recall Management System.
  • Established the Intellectual Property Management System and a comprehensive “Intellectual Property Reward System”.
  • Implemented strict information security control processes and formulated the “Company Confidentiality Management System”.
  • Provided anti-corruption and anti-commercial bribery training to the Group’s board of directors and staff.

Climate Goals & Targets

Medium-term Goals:
  • Expand manufacturing capacity to approximately 10,000 sets by the end of 2024.
Short-term Goals:
  • Reduce electricity consumption by 10%, water consumption by 5%, and gasoline consumption by 10% by 2023.
  • Reduce office energy consumption and per capita energy consumption by more than 10% by 2023.

Environmental Challenges

  • Extreme weather events impacting operations.
  • Intense competition in the medical device business.
  • Extensive government regulations impacting product development and commercialization.
  • Potential product liability claims.
Mitigation Strategies
  • Strengthening energy consumption management and implementing energy saving and emission reduction measures.
  • Building a professional and efficient commercialized team.
  • Complying with relevant laws and regulations.
  • Establishing a comprehensive production safety management system and a standardized management system.
  • Establishing a sound quality management system and product recall procedures.

Supply Chain Management

Supplier Audits: 699 suppliers audited in 2022

Responsible Procurement
  • Stringent selection process for suppliers.
  • Grading suppliers according to the impact of the purchased materials on the final products.
  • Conducting documentary and on-site audits on their production conditions, relevant qualification certificates and operational capabilities.

Climate-Related Risks & Opportunities

Physical Risks
  • Extreme weather events (heavy rainfall, typhoons, natural disasters)

Reporting Standards

Frameworks Used: Appendix 27 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, TCFD

Certifications: ISO14001, ISO45001

Third-party Assurance: Ernst & Young

Awards & Recognition

  • Top10 Innovative Listed Companies in China’s Health Industry 2022
  • Top100 Most Innovative Medical Technology Products 2022
  • Most Popular IPO Company
  • Most Valuable IPO of the Year

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:1346.1 tCO2e/year
Scope 1 Emissions:51.8 tCO2e/year
Scope 2 Emissions:1294.2 tCO2e/year
Total Energy Consumption:1.61 million kWh/year
Water Consumption:10499.3 m3/year
Waste Generated:4.3 tons (office paper) + 0.3 tons (packaging) + 6.5 kg (batteries)/year

ESG Focus Areas

  • Environmental
  • Social
  • Governance

Environmental Achievements

  • Reduced waste dry batteries discharge by strengthening recycling.
  • Reduced waste office paper discharge by improving management.

Social Achievements

  • Revised Employee Handbook to better protect employee rights.
  • Established a complaint reporting mechanism for employees.
  • Provided annual health check-ups for employees.
  • Organized regular work safety trainings for employees.
  • Developed a year-round training plan for employee development.
  • Established a workplace mentor system for new employees.
  • Established “Jenscare Academy” to enhance product knowledge for business personnel.

Governance Achievements

  • Complied with all applicable code provisions of the CG Code except for the separation of Chairman and CEO roles.
  • Implemented a set of effective procedures for the appointment of new Directors.
  • Adopted a diversity policy to enhance the effectiveness of the Board.
  • Established the Audit Committee, Remuneration and Appraisal Committee, Nomination Committee and Strategy Committee.
  • Adopted the Model Code as guidelines for Directors’ and Supervisors’ dealings in securities.
  • Established a whistleblowing policy and a system for employees to raise concerns.

Climate Goals & Targets

Long-term Goals:
  • Become a global leader in innovative solutions for structural heart diseases.
Short-term Goals:
  • Achieve 3% saving in electricity consumption, 3% saving in water consumption and 5% saving in fuel consumption in 2024.

Environmental Challenges

  • NMPA did not approve the registration application of LuX-Valve.
  • Significant operating losses since inception.
  • Need for additional financing to fund operations.
  • Fierce competition in the medical device business.
  • Challenges in international expansion.
Mitigation Strategies
  • Continue to pursue the commercialization of the LuX-Valve series of products.
  • Explore global business development cooperation and partnership.
  • Further optimize the Company’s product pipeline, strategically concentrate its resources on key core products, and accelerate the Company’s global commercialization process.
  • Implement risk management systems with relevant policies and procedures.
  • Strengthen supply guarantee capability and production continuity under climate change.

Supply Chain Management

Supplier Audits: 406 suppliers, all implemented management practices in 2023

Responsible Procurement
  • Stringent screening process for supplier selection.
  • Annual review of suppliers based on performance.

Climate-Related Risks & Opportunities

Awards & Recognition

  • Best-Performing Public Companies of 2023 Future Healthcare VB100
  • Best Performing Strategic Layout Cases of 2023 China-Go-Global Medical Device
  • 2023 Golden Kirin of Sina Finance – Most Growing Hong Kong Pharmaceutical Company
  • Most Valuable Pharmaceutical and Medical Company
  • 2023 Outstanding IR Team